| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 348,7 k € | -3.2% | 360,2 k € | +4.9% | 343,4 k € | -1.1% | 347,3 k € | +28.9% | 269,5 k € | +72.5% | 156,2 k € | -54.0% | 339,2 k € | -12.4% | 387,2 k € | +19.2% | 324,8 k € | -1.3% | 328,9 k € | +76.9% | 186,0 k € | +189.5% | 64,2 k € | +327.0% | -28,3 k € | |
| EBITDA | -5,1 k € | -122.1% | 23,3 k € | -37.1% | 37,0 k € | -43.1% | 65,0 k € | +264.5% | 17,8 k € | +126.2% | -68,1 k € | -230.8% | 52,1 k € | -15.1% | 61,4 k € | +84.7% | 33,2 k € | -51.7% | 68,9 k € | -62.9% | 185,5 k € | +190.8% | 63,8 k € | +316.0% | -29,5 k € | |
| Operating profit | -8,2 k € | -139.4% | 20,8 k € | +36.0% | 15,3 k € | -60.6% | 38,8 k € | +348.3% | -15,6 k € | +84.6% | -101,4 k € | -659.7% | 18,1 k € | -44.1% | 32,4 k € | +2165.3% | -1,6 k € | -104.6% | 34,2 k € | -77.5% | 152,4 k € | +378.6% | 31,8 k € | +170.3% | -45,3 k € | |
| Profit/loss | -27,7 k € | -1813.7% | 1,6 k € | +147.6% | -3,4 k € | -115.9% | 21,4 k € | +168.7% | -31,1 k € | +73.0% | -115,1 k € | -22098.8% | 523,4 € | -95.8% | 12,3 k € | +165.6% | -18,8 k € | -310.4% | 8,9 k € | -90.9% | 98,3 k € | +444.0% | 18,1 k € | +139.5% | -45,7 k € | |
| Equity | -62,2 k € | -80.6% | -34,4 k € | +4.5% | -36,0 k € | -10.4% | -32,6 k € | +39.6% | -54,0 k € | -135.9% | -22,9 k € | -124.8% | 92,2 k € | +0.6% | 91,7 k € | +15.5% | 79,4 k € | -19.2% | 98,2 k € | +10.0% | 89,3 k € | +1090.0% | -9,0 k € | +66.7% | -27,1 k € | |
| Total assets | 436,6 k € | +10.0% | 396,7 k € | +3.3% | 384,1 k € | -4.0% | 400,0 k € | +18.8% | 336,7 k € | +0.1% | 336,3 k € | -22.7% | 435,2 k € | +10.7% | 393,0 k € | -4.4% | 411,2 k € | -11.3% | 463,7 k € | +8.1% | 428,8 k € | +0.6% | 426,1 k € | +10.1% | 387,2 k € | |
| Cash | 11,8 k € | -47.6% | 22,5 k € | -20.2% | 28,2 k € | -64.3% | 78,9 k € | +211.4% | 25,3 k € | -30.4% | 36,4 k € | -41.2% | 61,8 k € | +93.0% | 32,0 k € | -34.9% | 49,2 k € | -7.8% | 53,4 k € | +45.4% | 36,7 k € | -16.9% | 44,2 k € | -85.1% | 296,2 k € | |
| Debts | 498,7 k € | +15.7% | 431,1 k € | +2.6% | 420,1 k € | -2.9% | 432,7 k € | +10.7% | 390,8 k € | +8.8% | 359,2 k € | +4.7% | 342,9 k € | +13.8% | 301,3 k € | -9.2% | 331,8 k € | -9.2% | 365,5 k € | +7.7% | 339,5 k € | -22.0% | 435,1 k € | +5.0% | 414,3 k € | |
| Staff | 5,7 | 5,9 | — | — | 4,9 | 5,2 | 5,6 | 6,9 | 5,7 | 4,9 | — | — | — | |||||||||||||
Private limited company · Schoten · incorporated on 16/07/2012 · 5,7 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-47.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APO CASDAN is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Schoten. It employs on average 5,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette